CRYSVITA
NDC 42747-304, Burosumab, injection, from Kyowa Kirin, Inc..
- Product NDC
- 42747-304
- Status
- Listed
- Labeler
- Kyowa Kirin, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761068
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42747-304 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUROSUMAB30 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42747-304-01 | 42747030401 | 1 VIAL, SINGLE-USE in 1 CARTON (42747-304-01) / 1 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/102f96a0-6e3a-4fc1-b204-34d604683af6Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=42747-304
Use it
Look up 42747-304 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42747-304 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42747-304. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.